Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 367 articles:
HTML format



Single Articles


    June 2022
  1. MURAMOTO Y, Nihira H, Shiokawa M, Izawa K, et al
    Anti-integrin alphavbeta6 antibody as a diagnostic marker for pediatric patients with ulcerative colitis.
    Gastroenterology. 2022 Jun 13. pii: S0016-5085(22)00631.
    PubMed    


  2. RICCIUTO A, Rauter I, McGovern DPB, Mader RM, et al
    Precision Medicine in Inflammatory Bowel Diseases: Challenges and Considerations for the Path Forward.
    Gastroenterology. 2022;162:1815-1821.
    PubMed    


  3. DELSUPEHE AM, Bourgain C, Bossuyt P
    Subtle Trap for the Inflammatory Bowel Disease Endoscopy Central Reader.
    Gastroenterology. 2022;162:1849-1851.
    PubMed    


  4. HANZEL J, Ma C, Jairath V
    Design of Clinical Trials for Mild to Moderate Crohn's Disease.
    Gastroenterology. 2022;162:1800-1814.
    PubMed    


  5. LIU CY, Girish N, Gomez ML, Dube PE, et al
    Transitional Anal Cells Mediate Colonic Re-epithelialization in Colitis.
    Gastroenterology. 2022;162:1975-1989.
    PubMed     Abstract available


  6. D'HAENS GR, Sandborn WJ, Loftus EV Jr, Hanauer SB, et al
    Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
    Gastroenterology. 2022;162:1876-1890.
    PubMed     Abstract available


  7. ZHU Z, Gao Z, Li K
    Controversy of Preoperative Exposure to Tumor Necrosis Factor Inhibitors in Surgical and Infectious Complications of Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jun 1. pii: S0016-5085(22)00588.
    PubMed    


    May 2022
  8. SABINO J
    Understanding the Role of PUFAs in Crohn's Disease.
    Gastroenterology. 2022;162:1590-1591.
    PubMed    


  9. SANDBORN WJ, D'Haens GR, Reinisch W, Panes J, et al
    Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
    Gastroenterology. 2022;162:1650-1664.
    PubMed     Abstract available


  10. SHODA T, Collins MH, Rochman M, Wen T, et al
    Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.
    Gastroenterology. 2022;162:1635-1649.
    PubMed     Abstract available


  11. SCHWARZLER J, Mayr L, Vich Vila A, Grabherr F, et al
    PUFA-Induced Metabolic Enteritis as a Fuel for Crohn's Disease.
    Gastroenterology. 2022;162:1690-1704.
    PubMed     Abstract available


    April 2022
  12. CROSS RK, Keefer L
    Chicken or Egg, Mental Health Disorders in Inflammatory Bowel Disease: Does It Matter?
    Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00454.
    PubMed    


  13. MA J, Wang Y, Cao H
    When neurology meets gastroenterology: an unusual case of ulcerative colitis.
    Gastroenterology. 2022 Apr 27. pii: S0016-5085(22)00447.
    PubMed    


  14. WILSON A, Kim RB
    Correspondence: Failure to Achieve Target Drug Concentrations During Induction and Not HLA- DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease - Is HLADQA1*05 gone before it's here?
    Gastroenterology. 2022 Apr 12. pii: S0016-5085(22)00367.
    PubMed    


  15. COHEN BL, Fleshner P, Kane SV, Herfarth HH, et al
    Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients with Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
    Gastroenterology. 2022 Apr 9. pii: S0016-5085(22)00359.
    PubMed    


  16. IRVING PM, Gecse KB
    Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives.
    Gastroenterology. 2022;162:1512-1524.
    PubMed     Abstract available


  17. PLEVRIS N, Lees CW
    Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities.
    Gastroenterology. 2022;162:1456-1475.
    PubMed     Abstract available


  18. STIDHAM RW, Takenaka K
    Artificial Intelligence for Disease Assessment in Inflammatory Bowel Disease: How Will it Change Our Practice?
    Gastroenterology. 2022;162:1493-1506.
    PubMed     Abstract available


  19. VERSTOCKT B, Parkes M, Lee JC
    How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?
    Gastroenterology. 2022;162:1383-1395.
    PubMed     Abstract available


  20. VERSTOCKT B, Bressler B, Martinez-Lozano H, McGovern D, et al
    Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?
    Gastroenterology. 2022;162:1370-1382.
    PubMed     Abstract available


  21. WILKENS R, Dolinger M, Burisch J, Maaser C, et al
    Point-of-Care Testing and Home Testing: Pragmatic Considerations for Widespread Incorporation of Stool Tests, Serum Tests, and Intestinal Ultrasound.
    Gastroenterology. 2022;162:1476-1492.
    PubMed     Abstract available


  22. LE BERRE C, Ricciuto A, Peyrin-Biroulet L, Turner D, et al
    Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last.
    Gastroenterology. 2022;162:1424-1438.
    PubMed     Abstract available


  23. KEEFER L, Bedell A, Norton C, Hart AL, et al
    How Should Pain, Fatigue, and Emotional Wellness Be Incorporated Into Treatment Goals for Optimal Management of Inflammatory Bowel Disease?
    Gastroenterology. 2022;162:1439-1451.
    PubMed     Abstract available


    March 2022
  24. VERSTOCKT S, Torres J, Verstockt B
    THE ROAD TO PROGNOSTICATION? A FIVE-PROTEIN PANEL PREDICTING DISEASE COURSE IN INFLAMMATORY BOWEL DISEASE.
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00289.
    PubMed    


  25. FAIRBRASS KM, Gracie DJ, Ford AC
    Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 years of Longitudinal Follow-up.
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00265.
    PubMed     Abstract available


  26. REVES J, Chapman TP, Satsangi J, Torres J, et al
    Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease-One Step Closer to Precision Medicine?
    Gastroenterology. 2022 Mar 23. pii: S0016-5085(22)00290.
    PubMed    


  27. RABINOWITZ LG, Rabinowitz DG, Silver EM, Oxentenko AS, et al
    Disparities persist in inclusion of female, pregnant, lactating, and older individuals in inflammatory bowel disease clinical trials.
    Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00267.
    PubMed    


  28. HAYASHI Y, Nakase H, Hisamatsu T
    Should we continue or discontinue inflammatory bowel disease medication in patients with COVID-19?
    Gastroenterology. 2022 Mar 11. pii: S0016-5085(22)00239.
    PubMed    


  29. HU MD, Golovchenko NB, Burns GL, Nair PM, et al
    gammadelta Intraepithelial Lymphocytes Facilitate Pathological Epithelial Cell Shedding Via CD103-Mediated Granzyme Release.
    Gastroenterology. 2022;162:877-889.
    PubMed     Abstract available


  30. GOBERT AP, Latour YL, Asim M, Barry DP, et al
    Protective Role of Spermidine in Colitis and Colon Carcinogenesis.
    Gastroenterology. 2022;162:813-827.
    PubMed     Abstract available


    February 2022
  31. PANES J, Colombel JF, D'Haens GR, Schreiber S, et al
    Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
    Gastroenterology. 2022 Feb 25. pii: S0016-5085(22)00199.
    PubMed     Abstract available


  32. HART A, Rubin DT
    Entering the Era of Disease Modification in Inflammatory Bowel Disease.
    Gastroenterology. 2022 Feb 11. pii: S0016-5085(22)00141.
    PubMed    


  33. ABRAHAM C, Abreu MT, Turner JR
    Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.
    Gastroenterology. 2022 Feb 8. pii: S0016-5085(22)00125.
    PubMed     Abstract available


  34. KHANNA R, Chande N, Marshall JK
    Ozanimod for the Treatment of Ulcerative Colitis.
    Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00088.
    PubMed    


  35. EDELMAN-KLAPPER H, Zittan E, Bar-Gil Shitrit A, Rabinowitz KM, et al
    Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFalpha.
    Gastroenterology. 2022;162:454-467.
    PubMed     Abstract available


  36. SANDS BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, et al
    Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
    Gastroenterology. 2022;162:495-508.
    PubMed     Abstract available


  37. STADNIK A, Wojcicki M, Milkiewicz P
    Splenic Tumor in a Patient After Liver Transplantation.
    Gastroenterology. 2022;162:e14-e15.
    PubMed    


    January 2022
  38. CLEVELAND NK, Torres J, Rubin DT
    WHAT DOES DISEASE PROGRESSION LOOK LIKE IN ULCERATIVE COLITIS AND HOW MIGHT IT BE PREVENTED?
    Gastroenterology. 2022 Jan 28. pii: S0016-5085(22)00077.
    PubMed     Abstract available


  39. SPENCER EA, Stachelski J, Dervieux T, Dubinsky MC, et al
    Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1*05 Carriage is Associated with Anti-Drug Antibody Formation in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2022 Jan 10. pii: S0016-5085(22)00017.
    PubMed    


  40. SEDANO R, Jairath V, Ma C, Sedano R, et al
    Design of clinical trials for mild-to-moderate ulcerative colitis.
    Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00004.
    PubMed    


  41. PRATT M, Forbes JD, Knox NC, Van Domselaar G, et al
    Colorectal cancer screening in IBD - can characterization of GI microbiome signatures enhance neoplasia detection?
    Gastroenterology. 2022 Jan 5. pii: S0016-5085(22)00007.
    PubMed     Abstract available


  42. KUENZIG ME, Fung SG, Marderfeld L, Mak JW, et al
    Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review.
    Gastroenterology. 2022 Jan 4. pii: S0016-5085(22)00002.
    PubMed     Abstract available


  43. LEVINE I, Swaminath A, Roitman I, Sultan K, et al
    COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution.
    Gastroenterology. 2022;162:349-350.
    PubMed    


  44. SAKURABA A, Luna A, Micic D
    Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.
    Gastroenterology. 2022;162:88-108.
    PubMed     Abstract available


  45. SEDANO R, Hogan M, Mcdonald C, Aswani-Omprakash T, et al
    Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical Trials.
    Gastroenterology. 2022;162:338-340.
    PubMed    


  46. YANG W, Liu H, Xu L, Yu T, et al
    GPR120 Inhibits Colitis Through Regulation of CD4(+) T Cell Interleukin 10 Production.
    Gastroenterology. 2022;162:150-165.
    PubMed     Abstract available


  47. BECKER HEF, Penders J, Jonkers DMAE
    Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations.
    Gastroenterology. 2022;162:4-8.
    PubMed    


  48. D'HAENS G, Rieder F, Feagan BG, Higgins PDR, et al
    Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Gastroenterology. 2022;162:26-31.
    PubMed    


  49. ALTEPETER T, Wertheimer E, Lee JJ
    Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Workshop to Identify Barriers and Move Forward.
    Gastroenterology. 2022;162:22-25.
    PubMed    


    December 2021
  50. LAMB CA, Saifuddin A, Powell N, Rieder F, et al
    The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease.
    Gastroenterology. 2021 Dec 14. pii: S0016-5085(21)04069.
    PubMed     Abstract available


  51. TORRES J, Ungaro RC, Colombel JF
    Is prevention the best way to modify inflammatory bowel disease? How close are we?
    Gastroenterology. 2021 Dec 11. pii: S0016-5085(21)04071.
    PubMed    


  52. D'AMICO F, Allocca M, Fiorino G
    Positioning ozanimod in ulcerative colitis: restoring leukocyte traffic under control.
    Gastroenterology. 2021 Dec 8. pii: S0016-5085(21)04063.
    PubMed    


  53. DARGENIO VN, Cristofori F, Francavilla R
    An unexpected guest in a patient with ulcerative colitis.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)04041.
    PubMed    


  54. FAYE AS, Dodson JA, Shaukat A
    Safety and Efficacy of Anti-TNF Therapy in Older Adults with Ulcerative Colitis: A New Path Forward.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03816.
    PubMed    


  55. SHEEHAN JL, Cohen-Mekelburg S
    Positioning infliximab and vedolizumab in the treatment of moderate-to-severe ulcerative colitis.
    Gastroenterology. 2021 Dec 2. pii: S0016-5085(21)03815.
    PubMed    


  56. CHAPMAN TP, Reves J, Torres J, Satsangi J, et al
    Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
    Gastroenterology. 2021;161:2057-2059.
    PubMed    


  57. GOLD SL, Cohen-Mekelburg S
    An Apple a Day Keeps the Doctor Away: The Effect of a Low-Fat, High-Fiber Diet on Quality of Life, Inflammation, and Dysbiosis in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03810.
    PubMed    


  58. LI X, Liang D, Huang B
    Reply.
    Gastroenterology. 2021;161:2066-2067.
    PubMed    


  59. ZHANG B, Zhang S
    The Potential of Radiomics in the Assessment of Intestinal Fibrosis in Crohn's Disease.
    Gastroenterology. 2021;161:2065-2066.
    PubMed    


  60. KUO WT, Zuo L, Odenwald MA, Madha S, et al
    The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.
    Gastroenterology. 2021;161:1924-1939.
    PubMed     Abstract available


    November 2021
  61. DI NARZO AF, Houten SM, Kosoy R, Huang R, et al
    Integrative analysis of the Inflammatory Bowel Disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03738.
    PubMed     Abstract available


  62. BOLTON C, Smillie CS, Pandey S, Elmentaite R, et al
    An integrated taxonomy for monogenic inflammatory bowel disease.
    Gastroenterology. 2021 Nov 12. pii: S0016-5085(21)03737.
    PubMed     Abstract available


  63. CAO Y, Wang Z, Yan Y, Ji L, et al
    Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p.
    Gastroenterology. 2021;161:1552-1566.
    PubMed     Abstract available


  64. LEE SH, Turpin W, Espin-Garcia O, Raygoza Garay JA, et al
    Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
    Gastroenterology. 2021;161:1540-1551.
    PubMed     Abstract available


    October 2021
  65. SHAH SC, Itzkowitz SH
    Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03707.
    PubMed    


  66. BEN-HORIN S, Novack L, Mao R, Guo J, et al
    Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: A systematic review and an individual-patient data meta-analysis of randomized controlled trials.
    Gastroenterology. 2021 Oct 29. pii: S0016-5085(21)03709.
    PubMed     Abstract available


  67. SPIERA E, Agrawal M, Ungaro R
    COVID-19 mRNA Vaccine Short-Term Safety in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Oct 6. pii: S0016-5085(21)03619.
    PubMed    


  68. KAPPELMAN MD, Weaver KN, Boccieri M, Firestine A, et al
    Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.
    Gastroenterology. 2021;161:1340-1343.
    PubMed    


  69. LIMA S, Gogokhia L, Viladomiu M, Chou L, et al
    Transferable IgA-coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Gastroenterology. 2021 Oct 1. pii: S0016-5085(21)03610.
    PubMed     Abstract available


  70. SASSON SC, Slevin SM, Cheung VTF, Nassiri I, et al
    Interferon-Gamma-Producing CD8(+) Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis.
    Gastroenterology. 2021;161:1229-1244.
    PubMed     Abstract available


  71. XIAO L, Ma XX, Luo J, Chung HK, et al
    Circular RNA CircHIPK3 Promotes Homeostasis of the Intestinal Epithelium by Reducing MicroRNA 29b Function.
    Gastroenterology. 2021;161:1303-1317.
    PubMed     Abstract available


    September 2021
  72. CLEVELAND NK, Rai V, El Jurdi K, Rao SS, et al
    ULCERATIVE COLITIS PATIENTS HAVE REDUCED RECTAL COMPLIANCE COMPARED WITH NON-IBD CONTROLS.
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03564.
    PubMed    


  73. SUGIMOTO S, Iwao Y, Shimoda M, Takabayashi K, et al
    Epithelium Replacement Contributes to Field Expansion of Squamous Epithelium and Ulcerative Colitis-Associated Neoplasia.
    Gastroenterology. 2021 Sep 28. pii: S0016-5085(21)03563.
    PubMed    


  74. COHEN NA, Silfen A, Rubin DT
    Inclusion of Under-Represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 22. pii: S0016-5085(21)03535.
    PubMed    


  75. KHANNA R, Wilson AS, Gregor JC, Prowse KL, et al
    Clinical Guidelines for the Management of Inflammatory Bowel Disease.
    Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03521.
    PubMed    


  76. PANES J
    Integrin inhibitors in inflammatory bowel disease: from therapeutic antibodies to small molecule drugs.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03495.
    PubMed    


  77. KONDO A, Ma S, Lee MYY, Ortiz V, et al
    Highly multiplexed image analysis of intestinal tissue sections in patients with inflammatory bowel disease.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03480.
    PubMed     Abstract available


  78. UNGARO RC, Brenner EJ, Agrawal M, Zhang X, et al
    Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03490.
    PubMed    


  79. ALLIN KH, Moayyedi P
    Proton pump inhibitor use - a risk factor for inflammatory bowel disease or an innocent bystander?
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03478.
    PubMed    


  80. VAN DE GUCHTE M, Mondot S, Dore J
    Dynamic properties of the intestinal ecosystem call for combination therapies, targeting inflammation and microbiota, in ulcerative colitis.
    Gastroenterology. 2021 Sep 6. pii: S0016-5085(21)03482.
    PubMed     Abstract available


  81. ARGMANN C, Tokuyama M, Ungaro RC, Huang R, et al
    Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension.
    Gastroenterology. 2021 Sep 1. pii: S0016-5085(21)03472.
    PubMed     Abstract available


  82. TURNER D, Hanauer SB
    Which Diet for Crohn's Disease? Food for Thought on the Specific Carbohydrate Diet, Mediterranean Diet, and Beyond.
    Gastroenterology. 2021;161:798-800.
    PubMed    


  83. SPARROW MP
    Quantification of Digestive Disease Damage in Crohn's Disease, Are We There Yet With the Lemann Index?
    Gastroenterology. 2021;161:800-802.
    PubMed    


  84. PONSIOEN CY, de Jonge WJ
    Feeding the Gut-Liver Axis in PSC: What Makes It Different from IBD?
    Gastroenterology. 2021;161:1070-1071.
    PubMed    


  85. SOFFER S, Kopylov U, Klang E
    Artificial Intelligence for the Evaluation of Mucosal Healing in IBD: The Future is Here.
    Gastroenterology. 2021;161:1073-1074.
    PubMed    


  86. MURTHY SK, Feuerstein JD, Nguyen GC, Velayos FS, et al
    AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review.
    Gastroenterology. 2021;161:1043-1051.
    PubMed     Abstract available


  87. LEWIS JD, Sandler RS, Brotherton C, Brensinger C, et al
    A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.
    Gastroenterology. 2021;161:837-852.
    PubMed     Abstract available


  88. PARIENTE B, Torres J, Burisch J, Arebi N, et al
    Validation and Update of the Lemann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.
    Gastroenterology. 2021;161:853-864.
    PubMed     Abstract available


  89. LE PH, Kuo CJ, Wu RC
    Colonic Bluish-Black Patches in a 57-Year-Old Woman with Crohn's Disease.
    Gastroenterology. 2021;161:e10-e11.
    PubMed    


    August 2021
  90. SANDBORN W, Mattheakis LC, Modi NB, Pugatch D, et al
    PTG-100, an Oral alpha4beta7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.
    Gastroenterology. 2021 Aug 30. pii: S0016-5085(21)03463.
    PubMed     Abstract available


  91. BARBERIO B, Massimi D, Cazzagon N, Zingone F, et al
    Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03412.
    PubMed     Abstract available


  92. POZDNYAKOVA V, Botwin GJ, Sobhani K, Prostko J, et al
    Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03360.
    PubMed    


  93. KUWADA T, Shiokawa M, Seno H
    Two novel autoantibodies in patients with ulcerative colitis.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03354.
    PubMed    


  94. XIA B, Yang M, Nguyen LH, He Q, et al
    Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of three prospective cohorts.
    Gastroenterology. 2021 Aug 10. pii: S0016-5085(21)03350.
    PubMed     Abstract available


  95. ROGLER G, Singh A, Kavanaugh A, Rubin DT, et al
    Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
    Gastroenterology. 2021 Aug 3. pii: S0016-5085(21)03337.
    PubMed     Abstract available


  96. JONES JL, Tse F, Carroll MW, deBruyn JC, et al
    Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Gastroenterology. 2021;161:681-700.
    PubMed     Abstract available


  97. WONG SY, Dixon R, Martinez Pazos V, Gnjatic S, et al
    Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies.
    Gastroenterology. 2021;161:715-718.
    PubMed    


  98. SARTOR RB
    Targeting Adaptive Immune Responses to Human Bacterial Flagellins in Crohn's Disease.
    Gastroenterology. 2021;161:416-418.
    PubMed    


  99. DUBINSKY MC, Collins R, Abreu MT
    Challenges and Opportunities in IBD Clinical Trial Design.
    Gastroenterology. 2021;161:400-404.
    PubMed    


  100. ALEXANDER KL, Zhao Q, Reif M, Rosenberg AF, et al
    Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
    Gastroenterology. 2021;161:522-535.
    PubMed     Abstract available


  101. FURFARO F, Solitano V, Danese S
    An Unusual Case of Cardiac Involvement in Crohn's Disease.
    Gastroenterology. 2021;161:431-433.
    PubMed    


    July 2021
  102. BERGEMALM D, Andersson E, Hultdin J, Eriksson C, et al
    Systemic inflammation in pre-clinical ulcerative colitis.
    Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03277.
    PubMed     Abstract available


  103. MEDERACKE I, Wiestler M, Wedemeyer H
    An unusual cause of erythema on both lower legs in a patient with Crohn s disease.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03249.
    PubMed    


  104. LECHNER K, Mott S, Al-Saifi R, Knipfer L, et al
    Targeting of the Tec kinase ITK drives resolution of T cell-mediated colitis and emerges as potential therapeutic option in ulcerative colitis.
    Gastroenterology. 2021 Jul 3. pii: S0016-5085(21)03186.
    PubMed     Abstract available


  105. BEN-TOV A, Banon T, Chodick G, Kariv R, et al
    BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Inflammatory Bowel Disease: Preliminary Real World Data during Mass Vaccination Campaign.
    Gastroenterology. 2021 Jul 2. pii: S0016-5085(21)03233.
    PubMed    


  106. PAPA A, Gasbarrini A, Lopetuso LR
    Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients.
    Gastroenterology. 2021;161:368-369.
    PubMed    


  107. RODRIGUEZ-PALACIOS A, Basson AR, Cominelli F
    Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?
    Gastroenterology. 2021;161:8-14.
    PubMed    


  108. DE A, Chen W, Li H, Wright JR, et al
    Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
    Gastroenterology. 2021;161:211-224.
    PubMed     Abstract available


    June 2021
  109. TAKADA Y, Ishikawa T, Kawashima H
    An unusual pancreatic mass with ductal disruption: benign or malignant?
    Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03173.
    PubMed    


  110. REINISCH W
    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
    PubMed    


  111. BAUMGARTNER M, Lang M, Holley H, Crepaz D, et al
    Mucosal biofilms are an endoscopic feature of irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 16. pii: S0016-5085(21)03138.
    PubMed     Abstract available


  112. PEYRIN-BIROULET L, Loftus EV Jr, Colombel JF, Danese S, et al
    Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03126.
    PubMed     Abstract available


  113. HADI YB, Thakkar S, Shah-Khan SM, Hutson W, et al
    COVID-19 vaccination is safe and effective in patients with inflammatory bowel disease: Analysis of a large multi-institutional research network in United States.
    Gastroenterology. 2021 Jun 15. pii: S0016-5085(21)03125.
    PubMed    


  114. MAHMUD N, Weiss A, Trivedi C, Yang YX, et al
    Risk of Venous Thromboembolism among Inflammatory Bowel Disease patients who contract SARS-CoV-2.
    Gastroenterology. 2021 Jun 14. pii: S0016-5085(21)03123.
    PubMed    


  115. NARULA N, Wong ECL, Dehghan M, Marshall JK, et al
    BRIEF COMMUNICATION: Does High Inflammatory Diet Increase Risk of Inflammatory Bowel Disease? Results from the Prospective Urban Rural Epidemiology (PURE) study: A Prospective Cohort Study.
    Gastroenterology. 2021 Jun 9. pii: S0016-5085(21)03096.
    PubMed    


  116. BARBERIO B, Buda A, Savarino EV
    Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
    Gastroenterology. 2021;160:2626-2627.
    PubMed    


  117. BEZZIO C, Saibeni S
    Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.
    Gastroenterology. 2021;160:2625-2626.
    PubMed    


  118. MAGO S, Vaziri H, Tadros M
    The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic.
    Gastroenterology. 2021;160:2623-2625.
    PubMed    


  119. PREIDIS GA, Su GL, Morgan RL
    Reply.
    Gastroenterology. 2021;160:2633-2635.
    PubMed    


  120. STANGE EF, von Bunau R, Erhardt A
    Ulcerative colitis-Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917.
    Gastroenterology. 2021;160:2632.
    PubMed    


  121. SHMIDT E, Ho EY, Feuerstein JD, Singh S, et al
    Spotlight: Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2511.
    PubMed    


  122. HO EY, Singh S, Terdiman JP
    Providing the Best Care for Patients With Crohn's Disease: An Examination of the New AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2557-2562.
    PubMed    


  123. SINGH S, Proctor D, Scott FI, Falck-Ytter Y, et al
    AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2512-2556.
    PubMed     Abstract available



  124. Medical Management of Adult Outpatients With Moderate to Severe Lunminal Crohn's Disease: Clinical Decision Support Tool.
    Gastroenterology. 2021;160:2509-2510.
    PubMed    


  125. FEUERSTEIN JD, Ho EY, Shmidt E, Singh H, et al
    AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Gastroenterology. 2021;160:2496-2508.
    PubMed    


  126. LORZADEH A, Romero-Wolf M, Goel A, Jadhav U, et al
    Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.
    Gastroenterology. 2021;160:2267-2282.
    PubMed     Abstract available


  127. LI X, Liang D, Meng J, Zhou J, et al
    Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.
    Gastroenterology. 2021;160:2303-2316.
    PubMed     Abstract available


  128. EDELMAN-KLAPPER H, Schwartz E, Ben-Horin S
    Visible Worms in a Crohn's Patient Treated with Infliximab.
    Gastroenterology. 2021;160:e10-e11.
    PubMed    


    May 2021
  129. KHAN N, Mahmud N
    Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications.
    Gastroenterology. 2021 May 25. pii: S0016-5085(21)03066.
    PubMed     Abstract available


  130. PAI N, Popov J, Hill L, Hartung E, et al
    Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00739.
    PubMed    


  131. STALGIS C, Deepak P, Mehandru S, Colombel JF, et al
    Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel Disease.
    Gastroenterology. 2021 May 4. pii: S0016-5085(21)00740.
    PubMed    


  132. OCCHIPINTI V, Saibeni S, Sampietro GM, Pastorelli L, et al
    Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect.
    Gastroenterology. 2021;160:2196-2197.
    PubMed    


  133. SAHA S, Mara K, Pardi DS, Khanna S, et al
    Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2021;160:1961-1969.
    PubMed     Abstract available


    April 2021
  134. AGRAWAL M, Spencer EA, Colombel JF, Ungaro RC, et al
    Approach to the management of recently diagnosed inflammatory bowel disease patients: a user's guide for adult and pediatric gastroenterologists.
    Gastroenterology. 2021 Apr 30. pii: S0016-5085(21)00734.
    PubMed     Abstract available


  135. RAJAMAKI K, Taira A, Katainen R, Valimaki N, et al
    Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer.
    Gastroenterology. 2021 Apr 27. pii: S0016-5085(21)00680.
    PubMed     Abstract available


  136. AGRAWAL M, Hillenbrand CM, Allin KH, Torres J, et al
    Early life greenspace and the risk of pediatric-onset inflammatory bowel disease: insights into the link between environmental and human health.
    Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00644.
    PubMed    


  137. SHEEHAN JL, Brandler J, Rice MD
    A Case of Recurrent Hepatic Abscesses.
    Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
    PubMed    


  138. TAXONERA C, Alba C, Olivares D
    What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
    Gastroenterology. 2021;160:1901-1902.
    PubMed    


  139. MAGRO F, Dias CC, Morato M
    Aminosalicylates and COVID-19: Facts or Coincidences?
    Gastroenterology. 2021;160:1884-1885.
    PubMed    


  140. RODRIGUEZ-LAGO I, Alonso-Galan H, Cabriada JL
    Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy.
    Gastroenterology. 2021;160:1878-1880.
    PubMed    


  141. RABINOWITZ LG, Kim MK, Wong SY
    Farnesoid X Receptor Variant: A Sex-based Determinant of Crohn's Disease Progression.
    Gastroenterology. 2021;160:1866-1867.
    PubMed    


  142. SHORT SP, Pilat JM, Barrett CW, Reddy VK, et al
    Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
    Gastroenterology. 2021;160:1694-1708.
    PubMed     Abstract available


  143. GETTLER K, Levantovsky R, Moscati A, Giri M, et al
    Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.
    Gastroenterology. 2021;160:1546-1557.
    PubMed     Abstract available


  144. QU JY, Li Z
    Is It a Crohn's Disease?
    Gastroenterology. 2021;160:1477-1478.
    PubMed    


    March 2021
  145. SOLITANO V, Vuitton L, Peyrin-Biroulet L, Danese S, et al
    The Evolution of Biologics Administration From Intravenous to Subcutaneous: Treatments for Inflammatory Bowel Disease Goes Home.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00548.
    PubMed    


  146. SHIRAI T, Kakuta Y, Fujii H
    Distinct autoantibodies against endothelial protein C receptor in ulcerative colitis.
    Gastroenterology. 2021 Mar 24. pii: S0016-5085(21)00547.
    PubMed    


  147. UNGER LW, Kaser A
    Is IL-6 back in trans signalling for inflammatory bowel disease?
    Gastroenterology. 2021 Mar 19. pii: S0016-5085(21)00539.
    PubMed    


  148. SCHREIBER S, Ben-Horin S, Leszczyszyn J, Dudkowiak R, et al
    Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.
    Gastroenterology. 2021 Mar 4. pii: S0016-5085(21)00474.
    PubMed     Abstract available


  149. SCHREIBER S, Aden K, Bernardes JP, Conrad C, et al
    Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease.
    Gastroenterology. 2021 Mar 2. pii: S0016-5085(21)00467.
    PubMed     Abstract available


  150. VERMEIRE S, Hebuterne X, Tilg H, De Hertogh G, et al
    Induction and long-term follow-up with ABX464 for moderate-to-severe ulcerative colitis: Results of phase 2a trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00459.
    PubMed    


  151. ILIEV ID, Cadwell K
    Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:1050-1066.
    PubMed     Abstract available


  152. LU R, Zhang YG, Xia Y, Zhang J, et al
    Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.
    Gastroenterology. 2021;160:1269-1283.
    PubMed     Abstract available


  153. KUMAR A, Priyamvada S, Ge Y, Jayawardena D, et al
    A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.
    Gastroenterology. 2021;160:1240-1255.
    PubMed     Abstract available


  154. AL-BAHLANI AQ, Kron CM, Hart L
    Chronic Diarrhea in a Pediatric Patient after Bone Marrow Transplantation.
    Gastroenterology. 2021;160:e10-e12.
    PubMed    


    February 2021
  155. BENCHIMOL EI, Tse F, Carroll MW, deBruyn JC, et al
    TEMPORARY REMOVAL: Canadian Association of Gastroenterology CLINICAL Practice Guideline For Immunizations in Patients with Inflammatory Bowel Disease (IBD). Part 2: Inactivated Vaccines.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00427.
    PubMed     Abstract available


  156. MA C, Sedano R, Almradi A, Casteele NV, et al
    An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials.
    Gastroenterology. 2021 Feb 18. pii: S0016-5085(21)00423.
    PubMed     Abstract available


  157. KUWADA T, Shiokawa M, Kodama Y, Ota S, et al
    Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients with Ulcerative Colitis.
    Gastroenterology. 2021 Feb 11. pii: S0016-5085(21)00406.
    PubMed     Abstract available


  158. COHEN RD, Feuerstein JD, Rubin DT
    REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020).
    Gastroenterology. 2021 Feb 6. pii: S0016-5085(21)00399.
    PubMed    


  159. NOWAK JK, Kalla R, Satsangi J
    SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical?
    Gastroenterology. 2021 Feb 4. pii: S0016-5085(21)00350.
    PubMed    


  160. KHANNA R, Afif W
    Ustekinumab for Ulcerative colitis.
    Gastroenterology. 2021 Feb 3. pii: S0016-5085(21)00340.
    PubMed    


  161. POTDAR AA, Dube S, Naito T, Li K, et al
    Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:809-822.
    PubMed     Abstract available


  162. TE GROEN M, Derks MEW, Kuijpers CCHJ, Nagtegaal ID, et al
    Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study.
    Gastroenterology. 2021;160:935-937.
    PubMed    


  163. PATANKAR JV, Chiriac MT, Lehmann M, Kuhl AA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.
    Gastroenterology. 2021;160:925-928.
    PubMed    


  164. MELMED GY, Rubin DT, McGovern DPB
    Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
    Gastroenterology. 2021;160:639-644.
    PubMed    


  165. BURGUENO JF, Fritsch J, Gonzalez EE, Landau KS, et al
    Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Gastroenterology. 2021;160:797-808.
    PubMed     Abstract available


  166. BARNES EL, Loftus EV Jr, Kappelman MD
    Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:677-689.
    PubMed     Abstract available


  167. CHUNG-YEE HUI R, Kuo KL, Yang TW
    A Rare Skin Complication Associated With Crohn's Disease.
    Gastroenterology. 2021;160:669-670.
    PubMed    


  168. KUMAR A, Magro C, Lukin DJ
    Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.
    Gastroenterology. 2021;160:e3-e5.
    PubMed    


    January 2021
  169. ZILBAUER M, Heuschkel R
    Reply to Lee et al.: Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00317.
    PubMed    


  170. MESERVE J, Singh S
    Pathologist, meet Picasso! Virtual chromoendoscopy for detecting histologic remission in ulcerative colitis.
    Gastroenterology. 2021 Jan 25. pii: S0016-5085(21)00318.
    PubMed    


  171. TAKENAKA K, Ohtsuka K, Fujii T, Oshima S, et al
    Deep neural network accurately predicts prognosis of ulcerative colitis using endoscopic images.
    Gastroenterology. 2021 Jan 21. pii: S0016-5085(21)00278.
    PubMed    


  172. RANDOLPH GJ, Czepielewski RS
    Response to: Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00270.
    PubMed    


  173. PINTO-SANCHEZ MI, Seiler C, Verdu EF
    Reply to: Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2021 Jan 20. pii: S0016-5085(21)00273.
    PubMed    


  174. BRAND EC, Klaassen MAY, Gacesa R, Vila AV, et al
    Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients.
    Gastroenterology. 2021 Jan 18. pii: S0016-5085(21)00097.
    PubMed     Abstract available


  175. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
    How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
    Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
    PubMed    


  176. KHAN N, Yang YX
    Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00071.
    PubMed    


  177. LEE JC, Lyons PA, McKinney EF
    Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".
    Gastroenterology. 2021 Jan 13. pii: S0016-5085(21)00081.
    PubMed    


  178. LE BERRE C, Peyrin-Biroulet L
    Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00016.
    PubMed     Abstract available


  179. CHEN E, Chuang LS, Giri M, Villaverde N, et al
    Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target.
    Gastroenterology. 2021 Jan 6. pii: S0016-5085(21)00024.
    PubMed     Abstract available


  180. SUAREZ-FARINAS M, Tokuyama M, Wei G, Huang R, et al
    Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.
    Gastroenterology. 2021;160:287-301.
    PubMed     Abstract available


  181. LEE M, Chang EB
    Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Gastroenterology. 2021;160:524-537.
    PubMed     Abstract available


  182. KELLERMAYER R, van der Laan M
    Validation of Predictive Models in Inflammatory Bowel Diseases.
    Gastroenterology. 2021;160:21-22.
    PubMed    


  183. NORSA L, D'Antiga L
    Reply.
    Gastroenterology. 2021;160:474-475.
    PubMed    


  184. SAZONOVS A, Ahmad T, Anderson CA
    Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab".
    Gastroenterology. 2021;160:470-471.
    PubMed    


  185. CASADEI C, Barberio B, Savarino E
    A Peculiar Cutaneous Manifestation in a Patient With Crohn's Disease.
    Gastroenterology. 2021;160:e1-e3.
    PubMed    


  186. ZHANG J, Hoedt EC, Liu Q, Berendsen E, et al
    Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation.
    Gastroenterology. 2021;160:317-330.
    PubMed     Abstract available


  187. RICCIUTO A, Aardoom M, Orlanski-Meyer E, Navon D, et al
    Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.
    Gastroenterology. 2021;160:403-436.
    PubMed     Abstract available


    December 2020
  188. UNGARO RC, Kappelman MD, Rubin DT, Colombel JF, et al
    COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
    Gastroenterology. 2020 Dec 30. pii: S0016-5085(20)35600.
    PubMed    


  189. TIAN Y, Zuo L
    Lymphatic-dependent transport of chylomicrons in inflammatory bowel disease.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35599.
    PubMed    


  190. TSE CS, Deepak P, Papadakis K
    Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35594.
    PubMed    


  191. WIJNANDS AM, de Jong ME, Lutgens MWMD, Hoentjen F, et al
    Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
    Gastroenterology. 2020 Dec 29. pii: S0016-5085(20)35587.
    PubMed     Abstract available


  192. SHIMIZU MS, Matsuo T, Mori N
    A rare manifestation associated with a urinary tract infection in a patient with ulcerative colitis.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35566.
    PubMed    


  193. TURNER D, Ricciuto A, Lewis A, D'Amico F, et al
    STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35572.
    PubMed     Abstract available


  194. DEVLIN JC, Axelrad J, Hine AM, Chang S, et al
    Single Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients.
    Gastroenterology. 2020 Dec 21. pii: S0016-5085(20)35571.
    PubMed     Abstract available


  195. IACUCCI M, Smith SC, Bazarova A, Shivaji UN, et al
    An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in Ulcerative Colitis.
    Gastroenterology. 2020 Dec 18. pii: S0016-5085(20)35563.
    PubMed     Abstract available


  196. WAUTERS L, Ceulemans M, Frings D, Lambaerts M, et al
    Proton pump inhibitors reduce duodenal eosinophilia, mast cells and permeability in patients with functional dyspepsia.
    Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35552.
    PubMed     Abstract available


  197. KIM ES, Tarassishin L, Eisele C, Barre A, et al
    Longitudinal Changes in Fecal Calprotectin Levels among Pregnant Women with and without Inflammatory Bowel Disease and Their Babies.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35532.
    PubMed     Abstract available


  198. VERSTOCKT B, Torres J
    Point-of-care intestinal ultrasound: prime time for the management of ulcerative colitis?
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35541.
    PubMed    


  199. GALIPEAU HJ, Caminero A, Turpin W, Bermudez-Brito M, et al
    Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis.
    Gastroenterology. 2020 Dec 8. pii: S0016-5085(20)35533.
    PubMed     Abstract available


  200. ROSEN MJ
    Could a Small Population of Epithelial Cells Get "Tuft" With Crohn's Disease?
    Gastroenterology. 2020;159:2025-2027.
    PubMed    


  201. KONG L, Lloyd-Price J, Vatanen T, Seksik P, et al
    Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.
    Gastroenterology. 2020;159:2193-2202.
    PubMed     Abstract available


  202. BANERJEE A, Herring CA, Chen B, Kim H, et al
    Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.
    Gastroenterology. 2020;159:2101-2115.
    PubMed     Abstract available


  203. TURPIN W, Lee SH, Raygoza Garay JA, Madsen KL, et al
    Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.
    Gastroenterology. 2020;159:2092-2100.
    PubMed     Abstract available


  204. COURTET A, Lemale J, Carra MC
    Generalized Gingival Hyperplasia and Rectorrhagia in a 13-Year-Old Boy.
    Gastroenterology. 2020;159:2030-2033.
    PubMed    


  205. ANGELINO G, Francalanci P, Tambucci R
    Terminal Ileum Thickening and Mucosal Ulcers in a Boy With Neurofibromatosis Type 1.
    Gastroenterology. 2020;159:e9-e11.
    PubMed    


    November 2020
  206. MAHADEVAN U, Long MD, Kane SV, Roy A, et al
    Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Nov 20. pii: S0016-5085(20)35441.
    PubMed     Abstract available


  207. TAXONERA C, Fisac J, Alba C
    Can COVID-19 trigger de novo inflammatory bowel disease?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35424.
    PubMed    


  208. FAIRBRASS KM, Gracie DJ, Ford AC
    In the Face of Adversity: Is Resilience Training a New Target for Inflammatory Bowel Disease Therapy?
    Gastroenterology. 2020 Nov 19. pii: S0016-5085(20)35417.
    PubMed    


  209. TORRES J, Riddle M, Colombel JF
    Answer to the letter by Rodriguez-Lago et al: Pre-inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Nov 4. pii: S0016-5085(20)35363.
    PubMed    


  210. KOCHAR B, Ananthakrishnan AN
    Reply.
    Gastroenterology. 2020;159:1993-1994.
    PubMed    


  211. ALLEGRETTI JR, Kelly CR, Grinspan A, Mullish BH, et al
    Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.
    Gastroenterology. 2020;159:1982-1984.
    PubMed    


  212. PARLATO M, Nian Q, Charbit-Henrion F, Ruemmele FM, et al
    Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation.
    Gastroenterology. 2020;159:1968-1971.
    PubMed    


  213. HUANG LH, Deepak P, Ciorba MA, Mittendorfer B, et al
    Postprandial Chylomicron Output and Transport Through Intestinal Lymphatics Are Not Impaired in Active Crohn's Disease.
    Gastroenterology. 2020;159:1955-1957.
    PubMed    


  214. SPALINGER MR, Sayoc-Becerra A, Santos AN, Shawki A, et al
    PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
    Gastroenterology. 2020;159:1763-1777.
    PubMed     Abstract available


    October 2020
  215. NAITO T, Botwin GJ, Haritunians T, Li D, et al
    Prevalence and Effect of Genetic Risk of Thrombo-embolic Disease in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Oct 19. pii: S0016-5085(20)35276.
    PubMed     Abstract available


  216. GOTTLIEB K, Requa J, Karnes W, Chandra Gudivada R, et al
    Central reading of ulcerative colitis clinical trial videos using neural networks.
    Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35283.
    PubMed     Abstract available


  217. BOSSUYT P, De Hertogh G, Eelbode T, Vermeire S, et al
    Computer aided diagnosis with monochromatic light endoscopy for scoring histological remission in ulcerative colitis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35246.
    PubMed    


  218. ANANTHAKRISHNAN AN, Nguyen GC, Bernstein CN
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in the Elderly: Expert Review.
    Gastroenterology. 2020 Oct 1. pii: S0016-5085(20)35219.
    PubMed    


  219. GARG M, Christensen B, Lubel JS
    Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
    Gastroenterology. 2020;159:1623-1624.
    PubMed    


  220. PARIGI TL, Bonifacio C, Danese S
    Is It Crohn's Disease?
    Gastroenterology. 2020;159:1244-1246.
    PubMed    


  221. TAKENAKA K, Ohtsuka K, Suzuki K, Watanabe M, et al
    Reply.
    Gastroenterology. 2020;159:1626-1627.
    PubMed    


  222. GORDON M, Guyatt G
    Assessment of Evidence Quality in Inflammatory Bowel Disease Guidance: The Use and Misuse of GRADE.
    Gastroenterology. 2020;159:1209-1215.
    PubMed    


  223. STENGEL ST, Fazio A, Lipinski S, Jahn MT, et al
    Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
    Gastroenterology. 2020;159:1357-1374.
    PubMed     Abstract available


  224. RAWAT M, Nighot M, Al-Sadi R, Gupta Y, et al
    IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.
    Gastroenterology. 2020;159:1375-1389.
    PubMed     Abstract available


    September 2020
  225. KELLY CR, Yen EF, Grinspan AM, Kahn SA, et al
    Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry.
    Gastroenterology. 2020 Sep 30. pii: S0016-5085(20)35221.
    PubMed     Abstract available


  226. MEYER EO, Aardoom M, Ricciuto A, Navon D, et al
    Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements from PIBD-Ahead Program.
    Gastroenterology. 2020 Sep 22. pii: S0016-5085(20)35206.
    PubMed     Abstract available


  227. ABREU MT, Sandborn WJ
    Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design.
    Gastroenterology. 2020 Sep 19. pii: S0016-5085(20)35168.
    PubMed    


  228. RODRIGUEZ-LAGO I, Marigorta UM, Acosta MB
    Preclinical inflammatory bowel disease: back to the future.
    Gastroenterology. 2020 Sep 12. pii: S0016-5085(20)35152.
    PubMed    


  229. PAUL S, Roblin X
    The Nightmare Monitoring of JAKinhibs.
    Gastroenterology. 2020;159:1188-1189.
    PubMed    


  230. TILG H, D'Haens G
    How to Manage Crohn's Disease After Ileocolonic Resection?
    Gastroenterology. 2020;159:816-820.
    PubMed    


  231. KANG JW, Yan J, Ranjan K, Zhang X, et al
    Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.
    Gastroenterology. 2020;159:1051-1067.
    PubMed     Abstract available


  232. KREISS L, Thoma OM, Dilipkumar A, Carle B, et al
    Label-Free In Vivo Histopathology of Experimental Colitis via 3-Channel Multiphoton Endomicroscopy.
    Gastroenterology. 2020;159:832-834.
    PubMed    


  233. HALL CHT, Lee JS, Murphy EM, Gerich ME, et al
    Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.
    Gastroenterology. 2020;159:984-998.
    PubMed     Abstract available


  234. PINTO-SANCHEZ MI, Seiler CL, Santesso N, Alaedini A, et al
    Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;159:884-903.
    PubMed     Abstract available


    August 2020
  235. NORSA L, Cosimo P, Indriolo A, Sansotta N, et al
    Asymptomatic SARS-CoV-2 infection in patients with inflammatory bowel disease under biologic treatment.
    Gastroenterology. 2020 Aug 26. pii: S0016-5085(20)35117.
    PubMed    


  236. LI K, Marano C, Zhang H, Yang F, et al
    Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
    Gastroenterology. 2020 Aug 24. pii: S0016-5085(20)35107.
    PubMed     Abstract available


  237. HERNDON JS, Vitta S, Weber FH Jr
    Marked Eosinophilia in a 27-Year-Old Woman with Recent Onset Ulcerative Colitis.
    Gastroenterology. 2020 Aug 20. pii: S0016-5085(20)35069.
    PubMed    


  238. GASPARETTO M, Payne F, Nayak K, Kraiczy J, et al
    Transcription and DNA Methylation patterns of blood derived CD8(+) T cells are associated with age and Inflammatory Bowel Disease but do not predict prognosis.
    Gastroenterology. 2020 Aug 16. pii: S0016-5085(20)35056.
    PubMed     Abstract available


  239. BOSSUYT P, Vermeire S, Bisschops R
    Assessing disease activity in ulcerative colitis using artificial intelligence: can "equally good" be seen as "better"?
    Gastroenterology. 2020 Aug 13. pii: S0016-5085(20)35044.
    PubMed    


  240. WALSHE M, Silverberg MS, Targownik LE
    What Constitutes Frailty In Inflammatory Bowel Disease?
    Gastroenterology. 2020 Aug 12. pii: S0016-5085(20)35045.
    PubMed    


  241. JANSSON-KNODELL CL, Walker MJ, Fischer M
    Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
    Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
    PubMed    


  242. HENN MR, O'Brien EJ, Diao L, Feagan BG, et al
    A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis.
    Gastroenterology. 2020 Aug 4. pii: S0016-5085(20)35012.
    PubMed     Abstract available


  243. BRENNER EJ, Ungaro RC, Gearry RB, Kaplan GG, et al
    Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
    Gastroenterology. 2020;159:481-491.
    PubMed     Abstract available


  244. STAHL E, Roda G, Dobbyn A, Hu J, et al
    Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
    Gastroenterology. 2020;159:549-561.
    PubMed     Abstract available


  245. POWELL DOHERTY RD, Liao H, Satsangi JJ, Ternette N, et al
    Extended Analysis Identifies Drug-Specific Association of 2 Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab.
    Gastroenterology. 2020;159:784-787.
    PubMed    


  246. APOSTOLOV R, Tan N, Vasudevan A
    Poor Bowel Preparation in Crohn's Disease.
    Gastroenterology. 2020;159:440-442.
    PubMed    


    July 2020
  247. BARBERIO B, Zingone F, Bertani L, Savarino E, et al
    The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients During COVID-19 Pandemic: Is It Really a Problem?
    Gastroenterology. 2020 Jul 17. pii: S0016-5085(20)34943.
    PubMed    


  248. KHANNA R, Zhou GY, Afif W
    Comparative Efficacy Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2020 Jul 15. pii: S0016-5085(20)34930.
    PubMed     Abstract available


  249. CAPPELLO M, Busacca A, Guida L
    The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an
    Gastroenterology. 2020 Jul 6. pii: S0016-5085(20)34920.
    PubMed    


  250. MOCCIARO F, Scimeca D, Di Mitri R
    THE COURAGE TO RETURN TO EVERYDAY LIFE AT THE TIME OF COVID-19: THE POINT OF VIEW OF INFLAMMATORY BOWEL DISEASE PATIENTS NEEDING ENDOSCOPY.
    Gastroenterology. 2020 Jul 1. pii: S0016-5085(20)34913.
    PubMed    


  251. NORSA L, Indriolo A, Sansotta N, Cosimo P, et al
    Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.
    Gastroenterology. 2020;159:371-372.
    PubMed    


  252. BERNSTEIN CN
    New Biomarkers for Crohn's Disease.
    Gastroenterology. 2020;159:30-32.
    PubMed    


  253. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.
    PubMed    


  254. ARDALAN ZS, Sparrow M, Gibson PR
    The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis.
    Gastroenterology. 2020;159:399-400.
    PubMed    


  255. PICKERT G, Wirtz S, Matzner J, Ashfaq-Khan M, et al
    Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.
    Gastroenterology. 2020;159:257-272.
    PubMed     Abstract available


  256. EL-MATARY W, Nugent Z, Bernstein CN, Singh H, et al
    Long-term Cancer Risk in Patients With Pediatric-Onset Inflammatory Bowel Diseases in the Canadian Population.
    Gastroenterology. 2020;159:386-387.
    PubMed    


  257. NAIR N, Austin C, Curtin P, Gouveia C, et al
    Association Between Early-life Exposures and Inflammatory Bowel Diseases, Based on Analyses of Deciduous Teeth.
    Gastroenterology. 2020;159:383-385.
    PubMed    


  258. UNGARO RC, Yzet C, Bossuyt P, Baert FJ, et al
    Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
    Gastroenterology. 2020;159:139-147.
    PubMed     Abstract available


  259. MULLIN GE, Chey WD, Crowe SE
    The 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease.
    Gastroenterology. 2020;159:20-25.
    PubMed    


  260. HEALY ME, Boege Y, Hodder MC, Bohm F, et al
    MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.
    Gastroenterology. 2020;159:183-199.
    PubMed     Abstract available


  261. TORRES J, Petralia F, Sato T, Wang P, et al
    Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Gastroenterology. 2020;159:96-104.
    PubMed     Abstract available


    June 2020
  262. YOON H, Jangi S, Dulai PS, Boland BS, et al
    Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020 Jun 22. pii: S0016-5085(20)34844.
    PubMed     Abstract available


  263. KHAN N, Patel D, Xie D, Pernes T, et al
    Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study.
    Gastroenterology. 2020 Jun 20. pii: S0016-5085(20)34845.
    PubMed    


  264. KJAERGAARD VS, Jensen CB, Elmahdi R, Burisch J, et al
    Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study.
    Gastroenterology. 2020 Jun 18. pii: S0016-5085(20)34830.
    PubMed    


  265. BANGMA A, Voskuil MD, Weersma RK
    TNFalpha-antagonist use and mucosal inflammation are associated with increased intestinal expression of SARS-CoV-2 host protease TMPRSS2 in patients with inflammatory bowel disease.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34783.
    PubMed    


  266. BRAIN O, Satsangi J
    Therapeutic decisions in inflammatory bowel disease in the SARS-Cov-2 pandemic.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34775.
    PubMed    


  267. CHEN J, Peng X, Zhang M, Zhi M, et al
    Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak.
    Gastroenterology. 2020 Jun 15. pii: S0016-5085(20)34779.
    PubMed    


  268. SINGH S, Khan A, Chowdhry M, Bilal M, et al
    Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study.
    Gastroenterology. 2020 Jun 6. pii: S0016-5085(20)34755.
    PubMed    


  269. RUETHER DF, Menz A, Manthey CF
    A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
    Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
    PubMed    


  270. SABINO J, Torres J
    You Are What You Eat, But Can Diet Prevent Inflammatory Bowel Diseases?
    Gastroenterology. 2020;158:2304-2305.
    PubMed    


  271. ZIDAR N
    Histopathology of Fibrosis in Crohn's Disease: The Importance of Understanding Its Pathogenesis.
    Gastroenterology. 2020;158:2313-2314.
    PubMed    


  272. BOUHNIK Y, Louis E, Peyrin-Biroulet L
    Looking for Innovative Digital Solutions to Optimize Patient Recruitment in Inflammatory Bowel Disease Trials.
    Gastroenterology. 2020;158:2306-2307.
    PubMed    


  273. KOLLEN L, Werner O, Gavotto A
    Uncommon Cause of Chest Pain in a 9-Year-Old Boy With Crohn's Disease.
    Gastroenterology. 2020;158:2055-2057.
    PubMed    


  274. KOCHAR B, Cai W, Cagan A, Ananthakrishnan AN, et al
    Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2020;158:2104-2111.
    PubMed     Abstract available


  275. CROWLEY E, Warner N, Pan J, Khalouei S, et al
    Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.
    Gastroenterology. 2020;158:2208-2220.
    PubMed     Abstract available


  276. SANDBORN WJ, Feagan BG, Loftus EV Jr, Peyrin-Biroulet L, et al
    Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
    Gastroenterology. 2020;158:2123-2138.
    PubMed     Abstract available


  277. LOEBENSTEIN M, Schulberg JD
    Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
    Gastroenterology. 2020;158:2069-2071.
    PubMed    


    May 2020
  278. LUKIN DJ, Kumar A, Hajifathalian K, Sharaiha RZ, et al
    Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2020 May 29. pii: S0016-5085(20)34738.
    PubMed    


  279. KHAN N, Patel D, Xie D, Lewis J, et al
    Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study.
    Gastroenterology. 2020 May 29. pii: S0016-5085(20)34737.
    PubMed    


  280. LEES CW, Regueiro M, Mahadevan U
    Innovation in IBD Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease.
    Gastroenterology. 2020 May 28. pii: S0016-5085(20)34735.
    PubMed    


  281. KALINE A, Bram V, Anabela SR, Severine V, et al
    Ex vivo mimicking of inflammation in organoids derived from patients with ulcerative colitis.
    Gastroenterology. 2020 May 28. pii: S0016-5085(20)34736.
    PubMed    


  282. TRIVEDI PJ, Crothers H, Mytton J, Bosch S, et al
    Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age.
    Gastroenterology. 2020 May 20. pii: S0016-5085(20)34702.
    PubMed     Abstract available


  283. BHAT S, Farraye FA, Moss A
    Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19.
    Gastroenterology. 2020 May 18. pii: S0016-5085(20)30677.
    PubMed    


  284. MITSIALIS V, Wall S, Liu P, Ordovas-Montanes J, et al
    Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Gastroenterology. 2020 May 16. pii: S0016-5085(20)30658.
    PubMed     Abstract available


  285. KOTZE PG, Peyrin-Biroulet L, Danese S
    Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic.
    Gastroenterology. 2020 May 15. pii: S0016-5085(20)30660.
    PubMed    


  286. KRZYSZTOF NJ, Christoffer LJ, Rahul K, Ricanek P, et al
    Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease.
    Gastroenterology. 2020 May 12. pii: S0016-5085(20)30653.
    PubMed    


  287. MACALUSO FS, Orlando A
    Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?
    Gastroenterology. 2020 May 11. pii: S0016-5085(20)30619.
    PubMed    


  288. LO CH, Lochhead P, Khalili H, Song M, et al
    Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30603.
    PubMed     Abstract available


  289. GOWER-ROUSSEAU C, Fumery M, Pariente B
    Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste.
    Gastroenterology. 2020 May 7. pii: S0016-5085(20)30605.
    PubMed    


  290. GUBATAN J, Levitte S, Balabanis T, Patel A, et al
    SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.
    Gastroenterology. 2020 May 6. pii: S0016-5085(20)30601.
    PubMed    


  291. OLIVERA PA, Lasa JS, Bonovas S, Danese S, et al
    Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.
    Gastroenterology. 2020;158:1554-1573.
    PubMed     Abstract available


    April 2020
  292. D'AMICO F, Danese S, Peyrin-Biroulet L
    Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn's and Colitis Organization (ECCO).
    Gastroenterology. 2020 Apr 30. pii: S0016-5085(20)30578.
    PubMed    


  293. RODRIGUEZ-LAGO I, Ramirez de la Piscina P, Elorza A, Merino O, et al
    Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).
    Gastroenterology. 2020 Apr 21. pii: S0016-5085(20)30560.
    PubMed    


  294. PARIGI TL, D'Amico F, Danese S
    Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot.
    Gastroenterology. 2020 Apr 17. pii: S0016-5085(20)30517.
    PubMed    


  295. HOLMER AK, Dulai PS
    Deep Learning Accurately Predicts Endoscopic and Histologic Remission in Ulcerative Colitis - What the Eye Doesn't See, the Artificial Mind Does Actually Know.
    Gastroenterology. 2020 Apr 11. pii: S0016-5085(20)30481.
    PubMed    


  296. RUBIN DT, Feuerstein JD, Wang AY, Cohen RD, et al
    AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
    Gastroenterology. 2020 Apr 10. pii: S0016-5085(20)30482.
    PubMed     Abstract available


  297. RUBIN DT, Abreu MT, Rai V, Siegel CA, et al
    Management of Patients with Crohn's Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting.
    Gastroenterology. 2020 Apr 6. pii: S0016-5085(20)30465.
    PubMed    


  298. FAYE AS, Colombel JF
    Age is Just a Number: How Frailty May Predict Outcomes Within Inflammatory Bowel Disease.
    Gastroenterology. 2020 Apr 2. pii: S0016-5085(20)30456.
    PubMed    



  299. Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.
    Gastroenterology. 2020;158:1462-1463.
    PubMed    


  300. ADEN K, Schreiber S, Rosenstiel P
    Reply.
    Gastroenterology. 2020;158:1512-1513.
    PubMed    


  301. CHEN J, Vitetta L
    Butyrate in Inflammatory Bowel Disease Therapy.
    Gastroenterology. 2020;158:1511.
    PubMed    


  302. JAZAYERI A, Nonga D, Rao M
    The Key to a Boy's Heart Is Through His Intestine.
    Gastroenterology. 2020;158:1226-1228.
    PubMed    


    March 2020
  303. BAMIAS G, Rivera-Nieves J, Mantzaris GJ
    Efficacy of IL12/23 blockade expands our therapeutic targets and challenges the old dogma in ulcerative colitis.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30366.
    PubMed     Abstract available


  304. SPENCER EA, Helmus D, Telesco S, Colombel JF, et al
    Inflammatory Bowel Disease Clusters Within Affected Sibships in Ashkenazi Jewish Multiplex Families.
    Gastroenterology. 2020 Mar 18. pii: S0016-5085(20)30365.
    PubMed    


  305. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
    Gastroenterology. 2020 Mar 10. pii: S0016-5085(20)30333.
    PubMed    


  306. DANESE S, Rimola J, Siegelman J
    Reply.
    Gastroenterology. 2020;158:1177-1178.
    PubMed    


  307. MACALUSO FS, Castiglione F, Rispo A, Orlando A, et al
    The VERSIFY Trial: What About Ultrasound Assessment?
    Gastroenterology. 2020;158:1176-1177.
    PubMed    


  308. GAUSMAN V, McNeill MB, Balzora S
    Facing Crohn's: A Rare Association.
    Gastroenterology. 2020;158:829-830.
    PubMed    


  309. APOSTOLOV R, Nicolaides S, Vasudevan A
    Complex Fistulizing Crohn's Disease.
    Gastroenterology. 2020;158:827-828.
    PubMed    


  310. PITTAYANON R, Lau JT, Leontiadis GI, Tse F, et al
    Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
    Gastroenterology. 2020;158:930-946.
    PubMed     Abstract available


  311. JARDINE S, Anderson S, Babcock S, Leung G, et al
    Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.
    Gastroenterology. 2020;158:1000-1015.
    PubMed     Abstract available


    February 2020
  312. SANDBORN WJ, Ghosh S, Panes J, Schreiber S, et al
    Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Gastroenterology. 2020 Feb 21. pii: S0016-5085(20)30241.
    PubMed     Abstract available


  313. PEREZ-JELDRES T, Alvarez-Lobos M, Nieves JR, Villablanca EJ, et al
    The cell circuitry of ulcerative colitis, a new view for a highly complex disease.
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30228.
    PubMed    


  314. TAKENAKA K, Ohtsuka K, Fujii T, Negi M, et al
    Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients with Ulcerative Colitis.
    Gastroenterology. 2020 Feb 11. pii: S0016-5085(20)30212.
    PubMed     Abstract available


  315. AGRAWAL M, Ungaro RC, Colombel JF
    New Blood Marker of Endoscopic Disease Activity-A Step Forward in Treating Crohn's Disease to Target?
    Gastroenterology. 2020;158:463-465.
    PubMed    


  316. FRITSCH J, Abreu MT
    Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition.
    Gastroenterology. 2020;158:470-472.
    PubMed    


  317. D'HAENS G, Kelly O, Battat R, Silverberg MS, et al
    Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
    Gastroenterology. 2020;158:515-526.
    PubMed     Abstract available


  318. SONDHI AR, Nayak LJ, Mowers J
    Cachexia, Colitis, and Cancer.
    Gastroenterology. 2020;158:488-490.
    PubMed    


    January 2020
  319. CHIBA M, Tsuji T, Komatsu M
    How to Optimize Effects of Infliximab in Inflammatory Bowel Disease: Incorporation of Plant-based Diet: Infliximab Optimization Needs Dietary Fiber.
    Gastroenterology. 2020 Jan 14. pii: S0016-5085(20)30106.
    PubMed    


  320. FEUERSTEIN JD, Isaacs KL, Schneider Y, Siddique SM, et al
    AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30018.
    PubMed    


  321. HAMMOUDI N, Bondeelle L, Gornet JM
    An unusual case of chronic cough revealing ulcerative colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30083.
    PubMed    


  322. KENNEDY J, Satsangi J, Chapman TP
    Just another flare of ulcerative colitis?
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30094.
    PubMed    


  323. SINGH S, Allegretti JR, Siddique SM, Terdiman JP, et al
    AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Gastroenterology. 2020 Jan 13. pii: S0016-5085(20)30019.
    PubMed     Abstract available


  324. LIM J, Hammami MB, Mahadevan U
    Infliximab Use in a Child with Ulcerative Colitis and Prior in utero Exposure to Infliximab.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30012.
    PubMed    


  325. KHALILI H, Burke KE, Roelstraete B, Sachs MC, et al
    Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.
    Gastroenterology. 2020 Jan 8. pii: S0016-5085(20)30008.
    PubMed     Abstract available


  326. PARK SH, Park SH
    Simplified Magnetic Resonance Index of Activity for Crohn's Disease-Let's Try to Kick It Up a Notch.
    Gastroenterology. 2020;158:281-282.
    PubMed    


  327. WILLIET N, Jardin S, Roblin X
    The Simplified Magnetic Resonance Index of Activity (MARIA) for Crohn's Disease Is Strongly Correlated With the MARIA and Clermont Score: An External Validation.
    Gastroenterology. 2020;158:282-283.
    PubMed    


  328. SAZONOVS A, Kennedy NA, Moutsianas L, Heap GA, et al
    HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
    Gastroenterology. 2020;158:189-199.
    PubMed     Abstract available


  329. SEIDELIN JB, Riis LB, Butt RA
    Crohn's Disease With Progressive Renal Impairment.
    Gastroenterology. 2020;158:58-59.
    PubMed    


  330. GORDON IO, Bettenworth D, Bokemeyer A, Srivastava A, et al
    Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.
    Gastroenterology. 2020;158:137-150.
    PubMed     Abstract available


    December 2019
  331. DANESE S
    New Drugs In The Ulcerative Colitis Pipeline: Prometheus Unbound.
    Gastroenterology. 2019 Dec 17. pii: S0016-5085(19)41924.
    PubMed    


  332. GRIMAUD F, Serrero M, Magalon J
    Adipose-Derived Therapeutic Products for the Management of Refractory Crohn's Fistula.
    Gastroenterology. 2019;157:1690-1691.
    PubMed    


  333. GUO Y, Bai AP
    Plasticity of Th17 Cells Contributes to Crohn's Disease.
    Gastroenterology. 2019;157:1689.
    PubMed    


  334. COOK L, Stahl M, Han X, Nazli A, et al
    Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Gastroenterology. 2019;157:1584-1598.
    PubMed     Abstract available


  335. HARRIS MS, Wichary J, Zadnik M, Reinisch W, et al
    Competition for Clinical Trials in Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1457-1461.
    PubMed    


  336. BITTAR JM, Burton K, Rahnama S
    Verrucous Plaques of the Buttocks, Perineum, and Umbilicus.
    Gastroenterology. 2019;157:1480-1482.
    PubMed    


  337. DEBOURDEAU A, Boivineau L, Iltache S
    The Little Beast That Pretended to Be a Severe Crohn's Disease.
    Gastroenterology. 2019;157:1483-1484.
    PubMed    


    November 2019
  338. VAZIRI H, Anderson JC
    Stool DNA for the Detection of High Grade Dysplasia and Adenocarcinoma in Patients with Inflammatory Bowel Disease.
    Gastroenterology. 2019 Nov 20. pii: S0016-5085(19)41584.
    PubMed    


  339. FUKUNAGA S, Kusaba Y, Tsuruta O
    Use of endocytoscopy for ulcerative colitis surveillance: A case study.
    Gastroenterology. 2019 Nov 15. pii: S0016-5085(19)41567.
    PubMed    


  340. SANDBORN WJ, Peyrin-Biroulet L, Zhang J, Chiorean M, et al
    Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis.
    Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41526.
    PubMed     Abstract available


  341. TORRES J
    Prediction of Inflammatory Bowel Disease: A Step Closer?
    Gastroenterology. 2019 Nov 5. pii: S0016-5085(19)41515.
    PubMed    


  342. ALAMEEL T, Al Sulais E
    Ustekinumab and Pregnancy: Continue or Cease Before You Conceive?
    Gastroenterology. 2019;157:1435.
    PubMed    


  343. BERNSTEIN CN
    Reply.
    Gastroenterology. 2019;157:1443-1444.
    PubMed    


  344. MAHADEVAN U, Fisher S, Riley L, Chambers C, et al
    Reply.
    Gastroenterology. 2019;157:1435-1436.
    PubMed    


  345. SHAH SC
    Friend or Foe in Inflammatory Bowel Disease Pathogenesis: Not All Infections Are Equal.
    Gastroenterology. 2019;157:1441-1442.
    PubMed    


  346. ZHU Y, Johnson LA, Rubin JM, Appelman H, et al
    Strain-Photoacoustic Imaging as a Potential Tool for Characterizing Intestinal Fibrosis.
    Gastroenterology. 2019;157:1196-1198.
    PubMed    


  347. KUO WT, Shen L, Zuo L, Shashikanth N, et al
    Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.
    Gastroenterology. 2019;157:1323-1337.
    PubMed     Abstract available


  348. BAR-YOSEPH H, Pressman S, Blatt A, Gerassy Vainberg S, et al
    Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.
    Gastroenterology. 2019;157:1338-1351.
    PubMed     Abstract available


  349. GUNTHER C, Ruder B, Stolzer I, Dorner H, et al
    Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1310-1322.
    PubMed     Abstract available


  350. HINDRYCKX P, Jairath V, Zou G, Feagan BG, et al
    Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1233-1244.
    PubMed     Abstract available


  351. ADEN K, Rehman A, Waschina S, Pan WH, et al
    Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1279-1292.
    PubMed     Abstract available


    October 2019
  352. PAPAMICHAEL K, Cheifetz AS
    Is It Prime Time for Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease?
    Gastroenterology. 2019;157:922-924.
    PubMed    


  353. GONCZI L, Bessissow T, Lakatos P
    Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:925-927.
    PubMed    


  354. GERASIMIDIS K, Svolos V, Nichols B, Papadopoulou R, et al
    Reply.
    Gastroenterology. 2019;157:1161-1162.
    PubMed    


  355. PARAMSOTHY S, Kaakoush NO
    Reply.
    Gastroenterology. 2019;157:1165-1166.
    PubMed    


  356. ASHTON JJ, Beattie RM
    Treatment of Active Crohn's Disease With an Ordinary Food-Based Diet That Replicates Exclusive Enteral Nutrition.
    Gastroenterology. 2019;157:1160-1161.
    PubMed    


  357. ALVARADO DM, Chen B, Iticovici M, Thaker AI, et al
    Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
    Gastroenterology. 2019;157:1093-1108.
    PubMed     Abstract available


  358. DANESE S, Sandborn WJ, Colombel JF, Vermeire S, et al
    Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Gastroenterology. 2019;157:1007-1018.
    PubMed     Abstract available


  359. LI K, Friedman JR, Chan D, Pollack P, et al
    Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:1019-1031.
    PubMed     Abstract available


  360. DULAI PS, Peyrin-Biroulet L, Danese S, Sands BE, et al
    Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases.
    Gastroenterology. 2019;157:1032-1043.
    PubMed     Abstract available


  361. ASSA A, Matar M, Turner D, Broide E, et al
    Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.
    Gastroenterology. 2019;157:985-996.
    PubMed     Abstract available


  362. LOWENBERG M, Vermeire S, Mostafavi N, Hoentjen F, et al
    Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Gastroenterology. 2019;157:997-1006.
    PubMed     Abstract available


    September 2019
  363. COX SR, Lindsay JO, Fromentin S, Stagg AJ, et al
    Effects of Low-FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Gastroenterology. 2019 Sep 27. pii: S0016-5085(19)41366.
    PubMed     Abstract available


  364. DE BACKER E, Bode H, Baert F
    New onset diffuse parenchymal lung disease in a 52-year old female with ulcerative colitis.
    Gastroenterology. 2019 Sep 24. pii: S0016-5085(19)41353.
    PubMed    


  365. XIAO L, Li XX, Chung HK, Kalakonda S, et al
    RNA-Binding Protein HuR Regulates Paneth Cell Function by Altering Membrane Localization of TLR2 via Post-transcriptional Control of CNPY3.
    Gastroenterology. 2019;157:731-743.
    PubMed     Abstract available


  366. PIOVANI D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, et al
    Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
    Gastroenterology. 2019;157:647-659.
    PubMed     Abstract available


    June 2019
  367. CHEN JCY, Halawi H, Loftus CG
    New Ascites and Omental Thickening in Ulcerative Colitis.
    Gastroenterology. 2019 Jun 14. pii: S0016-5085(19)41014.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: